Pfizer Canada supports Wellness Program for Extended Psychosis (W-PEP)

Pfizer Canada Inc. recently presented a donation of $30,000 to the Windsor Regional Hospital’s Wellness Program for Extended Psychosis (W-PEP). W-Pep provides screening, assessment and comprehensive state of the art treatment, including research and education, to individuals who are suffering from the debilitating illness of Schizophrenia and other related disorders.

Pfizer Canada Inc. is the Canadian operation of Pfizer Inc., the world’s leading Biopharmaceutical Company. Pfizer discovers, develops, manufactures and markets prescription medicines for human and animals. Pfizer Inc. invests more than US$7 billion annually in R&D to discover and develop innovative life-saving and life-enhancing medicines in a wide range of therapeutic areas. Our diversified health care portfolio includes human and animal biologic and small molecule medicines and vaccines, as many of the world’s best-known consumer products.

"This generous funding from Pfizer Pharmaceuticals will allow the W-PEP program to more effectively and efficiently provide treatment to patients with severe and persistent mental disorders by creating a Neuropsychiatric Metabolic Clinic," stated Dr. Len Cortese, Chief of Psychiatry for Windsor Regional Hospital. Dr. Cortese further said, "This new Clinic will allow a more comprehensive monitoring and assessment of these treatments to enhance a more positive outcome for our patients and their families."

"Pfizer’s support for the W-PEP program reflects our belief that it takes more than medication to improve disease management," said Sarah Mitton, Pfizer Brand Manager. "We are strongly committed to improving people’s health and we are proud to partner with the Windsor Regional Hospital."

Mental disorders represent the greatest burden and source of disability in our society, especially among the youth. It has been found that nearly three-quarters of all mental disorders begin between the ages of 16 and 25. Psychosis is the most serious of all mental disorders with a generally a poor outcome. Providing a comprehensive intervention program assists to improve the quality of life for these individuals and their families.